Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.645 USD | +0.30% | -5.71% | +6.45% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.45% | 128M | |
+18.82% | 125B | |
+13.86% | 108B | |
-7.53% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-14.04% | 16.37B | |
+2.04% | 13.58B | |
+27.72% | 11.66B |
- Stock Market
- Equities
- CTMX Stock
- News CytomX Therapeutics, Inc.
- BMO Capital Adjusts Price Target on CytomX Therapeutics to $3.59 From $3.25, Maintains Market Perform Rating